Metabolomic Responses to Oral Glucose Tolerance Test and Hyperinsulinemic–Euglycemic Clamp in CKD
Kidney360 · 2026-11 · 7 (11) · 2488-2498
DOI: 10.34067/kid.0000001322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, online erschienen am 01.09.2026. Verfasst von Armin Ahmadi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego, San Diego, California. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, Dialysis Clinics.
Abstract (Originalsprache)
Key Points Plasma metabolite responses to the oral glucose tolerance test and insulin clamp were largely directionally consistent, but most metabolites differed in magnitude. Discordant responses were rare and largely attributable to study design, while noncorresponding metabolites were predominantly involved amino acids. CKD did not substantially alter the direction of metabolic responses but was associated with reduced coordination and greater variability in magnitude.
Background
The oral glucose tolerance test (OGTT) captures integrated physiological responses involving intestinal glucose absorption, incretin signaling, and endogenous insulin secretion, whereas the hyperinsulinemic–euglycemic clamp (clamp) isolates insulin-mediated glucose uptake. Comparing plasma metabolomic responses with these 2 challenges may identify processes specific to intestinal nutrient delivery and how they vary in CKD.
Methods
Targeted plasma metabolomics was performed in 59 adults without diabetes (39 with CKD [eGFR
Autor:innen und Institutionen
- Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego, San Diego, California.
- Division of Nephrology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
- Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, California.
- Kinesiology Department, California State University, Sacramento, CA, USA.
- Division of Nephrology, Department of Internal Medicine, University of California, Davis, California.
- Department of Nutrition, University of California, Davis, CA, USA.
ORCID-Profile: Armin Ahmadi, Jorge Gamboa, Gwenaelle Begue, Brian J Bennett, Leila R Zelnick, Baback Roshanravan
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- Dialysis Clinics
- Diabetes Research Center, University of Washington
Zitieren
APA
Ahmadi, A., Gamboa, J., Fan, S., Begue, G., Bennett, B. J., Zelnick, L. R., de Boer, I. H., Cummings, B. P., & Roshanravan, B. (2026). Metabolomic Responses to Oral Glucose Tolerance Test and Hyperinsulinemic–Euglycemic Clamp in CKD. Kidney360, 7(11), 2488-2498. https://doi.org/10.34067/kid.0000001322
Vancouver
Ahmadi A, Gamboa J, Fan S, Begue G, Bennett BJ, Zelnick LR, et al. Metabolomic Responses to Oral Glucose Tolerance Test and Hyperinsulinemic–Euglycemic Clamp in CKD. Kidney360. 2026;7(11):2488-2498. doi:10.34067/kid.0000001322
BibTeX
@article{Ahmadi2026,
author = {Ahmadi, Armin and Gamboa, Jorge and Fan, Sili and Begue, Gwenaelle and Bennett, Brian J and Zelnick, Leila R and de Boer, Ian H and Cummings, Bethany P and Roshanravan, Baback},
title = {Metabolomic Responses to Oral Glucose Tolerance Test and Hyperinsulinemic–Euglycemic Clamp in CKD},
journal = {Kidney360},
year = {2026},
volume = {7},
number = {11},
pages = {2488--2498},
doi = {10.34067/kid.0000001322}
}
EUVIMED